Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules
yahoo.com
finance
2022-05-27 20:30:00

Alector LLC

SOUTH SAN FRANCISCO, Calif., May 27, 2022 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the compensation committee of Alector's board of directors granted Gary Romano, M.D., Ph.D., the company's newly-hired Chief Medical Officer, an inducement equity grant on May 27, 2022, consisting of inducement stock options to purchase an aggregate of 369,000 shares of the company's common stock and inducement restricted stock units, or RSUs, covering an aggregate of 92,250 shares of the company's common stock.
